Physio-Anatomy Clinical Data Collection Study

NCT ID: NCT05312164

Last Updated: 2025-03-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-03-14

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is an on-label clinical study design intended for the collection of three different types of interventional procedural data using FDA-cleared cardiac catheterization technologies and drugs, each used according to its product labeling and standard practice of medicine.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

These devices and drugs are commonly used for patient evaluation during PCI procedures performed by Interventional Cardiologists. The three device technologies used in a single catheterization laboratory visit for assessment of the coronary arteries include:

* A coronary angiography imaging system to X-ray the coronary arteries for the evaluation of vessel narrowing or blocking.
* Pressure guidewire from one or more manufacturers for the measurement of coronary physiology parameters.
* Gentuity® HF-OCT Imaging System with Vis-Rx® Micro-Imaging catheter for imaging and sizing of the stenosed coronary arteries.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Stenosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Candidates for PCI

Patients undergoing diagnostic cardiac catheterization/PCI.

HF-OCT Imaging

Intervention Type DEVICE

Subjects undergo HF-OCT imaging of stenosed coronary arteries

FFR Pressure Wire

Intervention Type DEVICE

Subjects undergo FFR physiology assessment of stenosed coronary arteries

Angiography

Intervention Type DEVICE

Subjects undergo angiography imaging of stenosed coronary arteries

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

HF-OCT Imaging

Subjects undergo HF-OCT imaging of stenosed coronary arteries

Intervention Type DEVICE

FFR Pressure Wire

Subjects undergo FFR physiology assessment of stenosed coronary arteries

Intervention Type DEVICE

Angiography

Subjects undergo angiography imaging of stenosed coronary arteries

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients \>18 years of age.
* Patients provide written informed consent.
* Clinical presentation consistent with suspected coronary disease.
* Patients who are candidates for PCI and scheduled for coronary diagnostics in the cardiac catheter lab with the intent to perform a physiological assessment for de novo lesions with stenosis, if clinically indicated.

Exclusion Criteria

* Presence of acute ST Elevation Myocardial Infarction (STEMI) at the time of the cath lab procedure.
* Contraindication for FFR examination or administration of vasodilators.
* Bacteremia or sepsis.
* Major coagulation system abnormalities.
* Severe hemodynamic instability or shock.
* Heart Failure NYHA Class IV.
* Severe valvular heart disease.
* Prior heart transplant.
* Acute renal failure based on diagnostic practice of the treating physician at time of screening.
* Patient is pregnant.
* Patient is currently enrolled in another clinical study that may impact the results of this study.
* Patient has other co-morbid condition(s) that, in the opinion of the Investigator, could limit their
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Gentuity, LLC

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Veteran's Administration Palo Alto

Palo Alto, California, United States

Site Status RECRUITING

Tampa General Hospital

Tampa, Florida, United States

Site Status RECRUITING

Atlanta VA Medical Center

Decatur, Georgia, United States

Site Status RECRUITING

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States

Site Status RECRUITING

Minneapolis VA Medical Center

Minneapolis, Minnesota, United States

Site Status RECRUITING

The Christ Hospital

Cincinnati, Ohio, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Arjun Bhat, MD, MBA

Role: CONTACT

978-202-4108

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Thanh Tran

Role: primary

813-844-8544

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

003785

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

OCT Evaluation of Healing of COMBO Stent
NCT01274234 COMPLETED PHASE1/PHASE2
Chronic Total Occlusion Registry
NCT02352818 RECRUITING
Precise Procedural and PCI Plan (P4)
NCT05253677 ACTIVE_NOT_RECRUITING NA